The launch includes AgeQ, a first-in-market biological age clinical assessment designed to provide early insights and guidance for healthier ageing....
The Xpert Xpress MVP test helped more women receive appropriate treatment within 24 hours compared with usual diagnostic methods....
The ClearFit AI integrated platform combines sonolucent implant technology, bedside ultrasound imaging, and artificial intelligence to support the future of postoperative brain visualisation...
The initiative will support placement of VMS+ cardiac imaging units to improve congenital heart disease assessment in underserved settings....
The CIZ1B biomarker test is being prepared for near-term availability to U.S. healthcare providers through OmniHealth Diagnostics....
The Xpert Hemorrhagic Fever panel will support decentralised molecular testing during the Ebola Bundibugyo outbreak in DRC and Uganda....
The clearance supports decentralized urine sample collection for molecular STI testing using Roche’s cobas platforms....
The technology has demonstrated successful light transmission through tissue-mimicking models and represents a significant step toward more precise, patient-friendly cancer treatment...
The Ejection Fraction AI tool is designed to support real-time cardiac assessment in primary care and emergency settings....
The FDA-cleared update adds spleen stiffness assessment, real-time elastography imaging and EHR connectivity, strengthening Hepatoscope’s role in point-of-care liver care. ...
